ArticleAdvances in hematology2014

Eculizumab therapy leads to rapid resolution of thrombocytopenia in atypical hemolytic uremic syndrome.

Han-Mou Tsai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.